Ignite Creation Date:
2024-05-06 @ 7:28 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06029153
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2023-09-01
Brief Title:
Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine
Sponsor:
The Affiliated Hospital Of Guizhou Medical University
Organization:
The Affiliated Hospital Of Guizhou Medical University
Study Overview
Official Title:
Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine a Single-arm Self-control Open-label Single-center Trial
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FAST-EM
Brief Summary:
This study is a single-arm self-controlled clinical trial that explores and evaluates the efficacy of middle meningeal artery embolization with coil in improving migraine symptoms The main objectives of the study are to evaluate the effectiveness and safety of the treatment
Detailed Description:
This study is a single-arm self-controlled open-label single-center clinical trial that explores and evaluates the efficacy of middle meningeal artery embolization with coil in improving migraine symptoms The inclusion criteria consist of patients with or without aura migraines who have experienced persistent chronic migraines for at least 3 months before screening and have shown resistance to at least two or more drug treatments with unsatisfactory therapeutic effects intolerable side effects or contraindications The main objectives of the study are to evaluate the effectiveness and safety of the treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None